Organization
Perspective Therapeutics
3 clinical trials
Clinical trial
A Phase I/IIa First-in-Human Study of [212Pb]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine TumorsStatus: Recruiting, Estimated PCD: 2026-09-30
Clinical trial
A Phase I/IIa, First-In-Human, Multi-Center Dose Escalation and Dose Expansion Study of [203/212Pb]VMT01 Receptor-Targeted, Image-Guided Alpha-Particle Therapy in Patients With Previously Treated Unresectable or Metastatic MelanomaStatus: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
A Phase 1 Cross-over Biodistribution Study of [203Pb]VMT01 for Single Photon Emission Computed Tomography (SPECT) Imaging and [68Ga]VMT02 for Positron Emission Tomography (PET) Imaging of Stage IV Metastatic MelanomaStatus: Completed, Estimated PCD: 2022-09-20